论文部分内容阅读
AIM To evaluate factors that influence the diagnostic accuracy of endoscopic ultrasound(EUS)-guided tissue acquisition for lymph node enlargement in the absence of an on-site pathologist. METHODS A retrospective analysis of patients who underwent EUS-guided tissue acquisition for the pathological diagnosis of lymph node enlargement between April2012 and June 2015 is reported. Tissue acquisition was performed with both cytology and biopsy needles of different calibers. The variables evaluated were lymph node location and size, number of passes and type of needle used. Final diagnosis was based on surgical histopathology or, in non-operated cases, on EUSguided tissue acquisition and imaging assessment with a minimum clinical follow-up of 6 mo. RESULTS During the study period, 168 lymph nodes with a median size of 20.3 mm(range 12.5-27) were sampled from 152 patients. Ninety lymph nodes(53.6%) were located at mediastinum, and 105(62.5%) were acquired with biopsy needles. The final diagnosis was benign/reactive origin in 87 cases(51.8%), malignant in 65 cases(38.7%), and lymphoma in 16 cases(9.5%). The sensitivity, specificity, positive predictive value and negative predictive value for the detection of malignancy were 74.1%, 100%, 100% and 80.6%, respectively. The overall accuracy was 87.5%(95%CI: 81.7-91.7). No variables were independently associated with a correct final diagnosis according to the multivariate analysis. CONCLUSION EUS-guided tissue acquisition is a highly accurate technique for assessing lymph node enlargement. None of the variables evaluated were associated with diagnostic accuracy.
AIM To evaluate factors that influence the diagnostic accuracy of endoscopic ultrasound (EUS) -guided tissue acquisition for lymph node enlargement in the absence of an on-site pathologist. METHODS A retrospective analysis of patients who underwent EUS-guided tissue acquisition for the pathological diagnosis of lymph node enlargement between April2012 and June 2015 is reported. Tissue acquisition was performed with both cytology and biopsy needles of different calibers. The rounded installation of lymph node location and size, number of passes and type of needle used. Final diagnosis was based on surgical histopathology or, in non-operated cases, on EUSguided tissue acquisition and imaging assessment with a minimum clinical follow-up of 6 months. RESULTS During the study period, 168 lymph nodes with a median size of 20.3 mm (range 12.5-27) were sampled from 152 patients. Ninety lymph nodes (53.6%) were located at mediastinum, and 105 (62.5%) were acquired with biopsy needles. The final diagnos The sensitivity, specificity, positive predictive value and negative predictive value for the detection of malignancy were (51.8%), malignant in 65 cases (38.7%), and lymphoma in 16 cases The overall accuracy was 87.5% (95% CI: 81.7-91.7). No variables were independently associated with a correct final diagnosis according to the multivariate analysis. CONCLUSION EUS- guided tissue acquisition is a highly accurate technique for assessing lymph node enlargement. None of the variables evaluated were associated with diagnostic accuracy.